Author
Listed:
- Sarah J. Lessard
(Joslin Diabetes Center
Brigham and Women’s Hospital and Harvard Medical School)
- Tara L. MacDonald
(Joslin Diabetes Center
Brigham and Women’s Hospital and Harvard Medical School)
- Prerana Pathak
(Joslin Diabetes Center)
- Myoung Sook Han
(University of Massachusetts Medical School)
- Vernon G. Coffey
(Bond University
RMIT University)
- Johann Edge
(Massey University)
- Donato A. Rivas
(Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University)
- Michael F. Hirshman
(Joslin Diabetes Center)
- Roger J. Davis
(University of Massachusetts Medical School
University of Massachusetts Medical School)
- Laurie J. Goodyear
(Joslin Diabetes Center
Brigham and Women’s Hospital and Harvard Medical School)
Abstract
Skeletal muscle has a remarkable plasticity to adapt and remodel in response to environmental cues, such as physical exercise. Endurance exercise stimulates improvements in muscle oxidative capacity, while resistance exercise induces muscle growth. Here we show that the c-Jun N-terminal kinase (JNK) is a molecular switch that when active, stimulates muscle fibers to grow, resulting in increased muscle mass. Conversely, when muscle JNK activation is suppressed, an alternative remodeling program is initiated, resulting in smaller, more oxidative muscle fibers, and enhanced aerobic fitness. When muscle is exposed to mechanical stress, JNK initiates muscle growth via phosphorylation of the transcription factor, SMAD2, at specific linker region residues leading to inhibition of the growth suppressor, myostatin. In human skeletal muscle, this JNK/SMAD signaling axis is activated by resistance exercise, but not endurance exercise. We conclude that JNK acts as a key mediator of muscle remodeling during exercise via regulation of myostatin/SMAD signaling.
Suggested Citation
Sarah J. Lessard & Tara L. MacDonald & Prerana Pathak & Myoung Sook Han & Vernon G. Coffey & Johann Edge & Donato A. Rivas & Michael F. Hirshman & Roger J. Davis & Laurie J. Goodyear, 2018.
"JNK regulates muscle remodeling via myostatin/SMAD inhibition,"
Nature Communications, Nature, vol. 9(1), pages 1-14, December.
Handle:
RePEc:nat:natcom:v:9:y:2018:i:1:d:10.1038_s41467-018-05439-3
DOI: 10.1038/s41467-018-05439-3
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:9:y:2018:i:1:d:10.1038_s41467-018-05439-3. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.